Kiniksa Pharmaceuticals International, plcKNSA

Market cap

$6.1B

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	72	47	114	122	123	108	184
Marketable securities, current	235	186	209	60	68	98	60
Total cash & short-term investments	308	234	324	182	191	206	244
Accounts receivable, net	-	-	-	4	13	21	42
Inventories	-	-	-	4	22	31	26
Total current assets	314	242	333	196	243	276	332
Property, plant and equipment, net	6	6	4	3	2	1	1
Total non-current assets	8	13	16	36	217	250	249
Total assets	322	255	349	233	460	526	581
Accounts payable	11	6	1	2	8	8	2
Total current liabilities	43	28	32	45	47	64	101
Total non-current liabilities	0	1	6	3	16	24	41
Total liabilities	43	29	38	48	64	87	142
Common stock and paid-in capital	473	581	829	860	888	917	960
Retained earnings	-194	-356	-517	-675	-492	-478	-521
Stockholders' equity	279	225	312	185	396	439	438
Working capital	-	-	-